Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using a robotic system to improve safety and efficiency in treating early gastric cancer

Official title: Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer: a Pilot Randomized Controlled Study

Run by Shandong University · NCT06748352 · Data updated 2026-11-12

This study is testing if a new robotic system can make the treatment for early gastric cancer safer and quicker compared to the usual method.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment50 (estimated)
SponsorShandong University
Academic / other
Locations1 site (Jinan, Shandong)
StatusRecruiting
StartedDecember 30, 2024
Main results expectedMarch 1, 2025
Study endsMarch 1, 2025
Registry record updatedDecember 27, 2024
Trial IDNCT06748352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-80 with pathologically verified high-grade intraepithelial neoplasia or intramucosal carcinoma of the stomach.

Probably not a fit

Patients with deep submucosal invasion, lymph node metastasis, or severe underlying conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of the flexible auxiliary single-arm transluminal endoscopic robot (FASTER) system to enhance the safety and efficacy of endoscopic submucosal dissection (ESD) for early gastric cancer. Participants will be randomly assigned to receive either traditional ESD or FASTER-assisted ESD. The study aims to determine if the robotic system can reduce muscular injuries and procedure time compared to conventional methods. Patients will also keep a diary of their symptoms post-procedure to monitor outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to safer and more efficient treatment options for patients with early gastric cancer.

How similar studies have gone: While robotic-assisted procedures are gaining traction, this specific application of the FASTER system in ESD is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18-80.
* Patients with pathologically verified high-grade intraepithelial neoplasia (HGIN) or intramucosal carcinoma of the stomach.

Exclusion Criteria:

* Patients have lesions with confirmed or potential deep submucosal invasion or lymph node metastasis.
* Patients with severe underlying diseases precluding endotracheal intubation, general anesthesia, or surgery.
* Patients have a history of gastric malignancy with previous radiotherapy or operative treatment leading to changes in gastric structure.
* Patients have lesions with local recurrence after endoscopic resection.
* Patients unable to obtain informed consent.

Where it's running

  • Qilu Hospital of Shandong University
    Jinan, Shandong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.